Heparin Sodium Injection — FDA Drug Shortage

No longer listed by FDA — Hospira, Inc., A Pfizer Company

The FDA lists a drug shortage record for Heparin Sodium Injection (injection) from Hospira, Inc., A Pfizer Company with status No longer listed by FDA. The shortage was first posted on Nov 14, 2017.

Shortage details

Status
No longer listed by FDA
Company
Hospira, Inc., A Pfizer Company
Package NDC
0409-7620-03
Dosage Form
Injection
Presentation
Heparin Sodium, Injection, 1,000 Units/500 mL (2 Units/mL) (NDC 0409-7620-03)
Initial Posting
Nov 14, 2017

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.